Spotlight on Eli Lilly and Co: Analyzing the Surge in Options

Jun 17, 2024 · Eli Lilly and Co's Current Market Status Currently trading with a volume of 65,069, the LLY's price is down by -0.18%, now at $876.87. RSI readings suggest the stock is …

18%
OFF

Spotlight On Eli Lilly And Co: Analyzing The Surge In Options

2 weeks from now

Jun 17, 2024 · Eli Lilly and Co's Current Market Status Currently trading with a volume of 65,069, the LLY's price is down by -0.18%, now at $876.87. RSI readings suggest the stock is …

nasdaq.com

$430
OFF

Spotlight On Eli Lilly: Analyzing The Surge In Options Activity

2 weeks from now

Sep 23, 2024 · Predicted Price Range Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $430.0 to …

nasdaq.com

$400
OFF

Behind The Scenes Of Eli Lilly's Latest Options Trends

2 weeks from now

Nov 29, 2024 · Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $400.0 to $1000.0 for Eli Lilly during the past …

nasdaq.com

$330
OFF

Smart Money Is Betting Big In LLY Options - Eli Lilly (NYSE:LLY)

2 weeks from now

Jan 3, 2025 · Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Eli Lilly's whale activity within a strike price range from $330.0 to …

benzinga.com

$500
OFF

Decoding Eli Lilly's Options Activity: What's The Big Picture?

2 weeks from now

Oct 23, 2024 · Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $500.0 to $1260.0 for Eli Lilly during the past …

nasdaq.com

$1300
OFF

Eli Lilly Stock: What's There To Like? - Investor's Business Daily

2 weeks from now

17 hours ago · Option Trade Could Return More Than $1,300 On A Wobbly Eli Lilly. 1/15/2025 Eli Lilly stock has been struggling since mid-August and could provide a nice bearish candidate. …

investors.com

$700
OFF

Eli Lilly: Big 2025 Ahead, But Execution Risks Exist

2 weeks from now

12 hours ago · Eli Lilly has regularly traded down to the $700 to $750 range over the last year. The stock isn't necessarily cheap at 33x the 2025 EPS target of $22.62, but the company is …

seekingalpha.com

28%
OFF

Eli Lilly's Options: A Look At What The Big Money Is Thinking

2 weeks from now

Oct 1, 2024 · Today, Benzinga's options scanner spotted 28 uncommon options trades for Eli Lilly. This isn't normal. The overall sentiment of these big-money traders is split between 28% …

nasdaq.com

$440
OFF

Behind The Scenes Of Eli Lilly's Latest Options Trends

2 weeks from now

Oct 18, 2024 · Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $440.0 to $1340.0 for Eli Lilly during the past …

nasdaq.com

FAQs about Spotlight on Eli Lilly and Co: Analyzing the Surge in Options Coupon?

Should you buy Eli Lilly & Co (ell)?

Consistent in their evaluation, an analyst from Jefferies keeps a Buy rating on Eli Lilly and Co with a target price of $957. An analyst from Cantor Fitzgerald has revised its rating downward to Overweight, adjusting the price target to $885. Options trading presents higher risks and potential rewards. ...

Is Eli Lilly a good stock to buy in 2024?

Members of Out Fox The Street get exclusive ideas and guidance to navigate any climate. Learn More » Eli Lilly and Company (NYSE: LLY) had a strong year in 2024, but the stock dipped to end the year. Due to the enormous growth rate and supply issues for GLP-1 drugs, investors shouldn't get lost focusing on quarter-to-quarter results. ...

How much will Eli Lilly make in 2025?

Eli Lilly guided up to 2025 revenue of $58 to $61 billion, with analysts currently just above $58 billion. The guidance predicts sales growth of 32% for the year, and the management team actually started 2024 off with a conservative number of only $41 billion. ...

Will Eli Lilly make more incretins in 2025?

We'll also bring additional manufacturing capacity online and expect to produce at least 60% more salable doses of incretins in the first half of the year compared to the first half of 2024. Eli Lilly guided up to 2025 revenue of $58 to $61 billion, with analysts currently just above $58 billion. ...

Why did Eli Lilly's stock drop in Q4?

Eli Lilly and Company's stock dipped due to cutting Q4 sales targets despite a strong 2024 performance from drugs Mounjaro and Zepbound. The biopharma forecasts 2025 revenue of $58-$61 billion for 32% sales growth, driven by significant production increases in the first half. ...

What's a good price band for Eli Lilly & Co?

After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $430.0 and $1000.0 for Eli Lilly and Co, spanning the last three months. Insights into Volume & Open Interest Looking at the volume and open interest is a powerful move while trading options. ...